US Dividends Aristocrats thread

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
JP Morgan announces new division to fund at least $100 billion in emerging-market projects
JAN 21 2020

J.P. Morgan Chase announced the creation of a new business called the Development Finance Institution to boost private investment in emerging-market development projects.

“The emerging markets are where the action is,” Allibhoy told CNBC. Places like Indonesia, Turkey, Mexico and Egypt are “countries that are building infrastructure and that are in need of capital, and they’re sizable economies.”

moi ish agree on EM. but on another hand, they ish BB with cash to burn, and able to sit on losses for years.
can I? dun think so.
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
Halliburton Announces Fourth Quarter 2019 Results
January 21, 2020

Total revenue for the full year of 2019 was $22.4 billion, a decrease of $1.6 billion, or 7%, from 2018. Reported operating loss for 2019 was $448 million, compared to a reported operating income of $2.5 billion for 2018. Excluding impairments and other charges, adjusted operating income for 2019 was $2.1 billion, compared to adjusted operating income of $2.7 billion for 2018.

“I am pleased with how Halliburton executed for the fourth quarter and the full year. We optimized our performance in North America as the market softened, and our international business grew for the second year in a row,” commented Jeff Miller, Chairman, President and CEO.

“We delivered over $900 million of free cash flow for the full year 2019, demonstrating our ability to generate consistent free cash flow throughout different business environments.
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
maybe i shud do dis long ago:

any1 else have stock analysis requests? US listed only.

dun care copyright anot alrdy. going to cancel subscription dis year anyway :s13:
 

Perisher

Greater Supremacy Member
Deluxe Member
Joined
Jan 5, 2015
Messages
84,164
Reaction score
10,089
maybe i shud do dis long ago:

any1 else have stock analysis requests? US listed only.

dun care copyright anot alrdy. going to cancel subscription dis year anyway :s13:

GLPG
MRVL
ABBV
LDOS
AMD
MAIN
AWK
BDX
RTN
RDS.B
IBB
NDAQ
BR
HD
BMY
SCI
WM

and then some... :s13:
I removed the popular ones that I hold, these are the less well known to most people.
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
Johnson & Johnson Reports 2019 Fourth-Quarter and Full Year Results
January 22, 2020

“As we enter into 2020 and this next decade, our strategic investments focused on advancing our pipelines and driving innovation across our entire product portfolio, position us well to deliver long-term sustainable growth and value to our shareholders.”

Mr. Gorsky continued, “I am extremely proud of our talented and dedicated colleagues who live Our Credo values each and every day, and are inspired to deliver transformative healthcare solutions that improve the lives of our patients and consumers around the world.”

jnj condoms? :s22:
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
IBM REPORTS 2019 FOURTH-QUARTER AND FULL-YEAR RESULTS
January 21, 2020

“In 2019, we continued to invest in the higher-value growth areas of the industry and took bold actions — including several divestitures and a major acquisition — to position our business, which are reflected in our strong gross margin performance," said James Kavanaugh, IBM senior vice president and chief financial officer. "After completing the acquisition of Red Hat, and with strong free cash flow and disciplined financial management, we significantly deleveraged in the second half.”
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
Dividend Aristocrats In Focus Part 54: AbbVie
January 20th, 2020

AbbVie is a very high-quality business, with a strong pharmaceutical pipeline and growth potential. It is also a shareholder-friendly company that returns excess cash flow to investors through stock buybacks and dividends.

AbbVie faces a significant challenge in replacing lost Humira sales as it faces competition in the U.S. and Europe. Fortunately, the company has prepared for this with heavy R&D investments. From this, it has created a large portfolio of new products that should keep AbbVie’s growth intact. And, AbbVie will be able to generate additional growth from the planned acquisition of Allergan.

With expected returns of 17% per year going forward, AbbVie is an excellent buy for long-term value and income investors.
 

Mr. Wood

Banned
Joined
Oct 4, 2013
Messages
26,961
Reaction score
5,127
Dividend Aristocrats In Focus Part 55: PepsiCo
January 21st, 2020

PepsiCo is a very strong business, with a number of category-leading brands. By investing heavily in new products and acquisitions, it is likely to continue growing sales and earnings for many years.

Shareholders should continue to benefit from PepsiCo’s strong business through annual dividend increases. The stock is overvalued, which means value investors should wait for a more attractive entry point before buying shares.

That said, PepsiCo remains a valuable holding for a dividend growth portfolio
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ Forums. Forum members and moderators are responsible for their own posts. Please refer to our Community Guidelines and Standards and Terms and Conditions for more information.
Top